Inserm Transfert

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2020	Eyevensys	$30.0M Series B	Boehringer Ingelheim	Pureos Bioventures, Bpifrance, Neena Kadaba, Karista, Pontifax, Dominik Escher, Quark Venture

Total Raised

N/A

Valuation

N/A

Key people at Inserm Transfert.

Jean-Michel Gauthier

Key people at Inserm Transfert.

Jean-Michel Gauthier